BioHarvest Sciences Inc.
BHST
$6.55
-$0.05-0.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 11.30% | 8.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.30% | 8.50% | |||
| Cost of Revenue | 11.68% | -3.42% | |||
| Gross Profit | 11.01% | 19.73% | |||
| SG&A Expenses | -2.75% | 19.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.75% | 10.74% | |||
| Operating Income | 19.74% | -18.36% | |||
| Income Before Tax | -9.63% | -291.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.93% | -291.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.93% | -291.41% | |||
| EBIT | 19.74% | -18.36% | |||
| EBITDA | 10.09% | -23.40% | |||
| EPS Basic | -9.93% | -269.29% | |||
| Normalized Basic EPS | -9.70% | -268.44% | |||
| EPS Diluted | -9.93% | -269.29% | |||
| Normalized Diluted EPS | -9.70% | -268.44% | |||
| Average Basic Shares Outstanding | -0.03% | 6.07% | |||
| Average Diluted Shares Outstanding | -0.03% | 6.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||